Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v7.7)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1 - 11

Query Trace: Osteosarcoma and MTHFR[original query]

Association of MTHFR and ABCB1 polymorphisms with MTX-induced mucositis in Chinese paediatric patients with acute lymphoblastic leukaemia, lymphoma or osteosarcoma-A retrospective cohort study. Journal of clinical pharmacy and therapeutics 2021 Aug . Gong Yan, Luo Li, Wang Liu, Chen Jun, Chen Fen, Ma Yuanyuan, Xu Zhen, Sun Yiqi, Luo Lin, Shi Chen, Li Xinga Similar articles in PubMed
MTHFR variant is associated with high-dose methotrexate-induced toxicity in the Chinese osteosarcoma patients. Journal of bone oncology 2018 Nov 13 143-147. Xu Leilei, Wang Lujun, Xue Bingchuan, Wang Shoufe Similar articles in PubMed
More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate. Oncotarget 2018 Feb 9 (14): 11465-11476. Xie Lu, Guo Wei, Yang Yi, Ji Tao, Xu J Similar articles in PubMed
The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients. Pharmacogenomics 2017 Jun . Lambrecht Loes, Sleurs Charlotte, Labarque Veerle, Dhooge Catharina, Laenen Annouschka, Sinnaeve Friedl, Renard Marleen, Uyttebroeck An Similar articles in PubMed
ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma. Journal of pediatric hematology/oncology 2017 Mar . Park Jeong A, Shin Hee You Similar articles in PubMed
Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma. Blood research 2016 Mar 51 (1): 50-7. Park Jeong A, Shin Hee You Similar articles in PubMed
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate. The pharmacogenomics journal 2015 Oct 15 (5): 385-90. Jabeen S, Holmboe L, Alnæs G I G, Andersen A M, Hall K S, Kristensen V Similar articles in PubMed
Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. Cancer 2012 Apr 118 (7): 1856-67. Windsor Rachael E, Strauss Sandra J, Kallis Constantinos, Wood Nicholas E, Whelan Jeremy Similar articles in PubMed
Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients. Asian Pacific journal of cancer prevention : APJCP 2012 13 (4): 1553-6. Dogan Mutlu, Karabulut Halil G, Tukun Ajlan, Demirkazik Ahmet, Utkan Gungor, Yalcin Bulent, Dincol Dilek, Akbulut Hakan, Icli Fik Similar articles in PubMed
Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression. The Journal of pediatrics 2009 May 154 (5): 688-93. Patiño-García Ana, Zalacaín Marta, Marrodán Lucía, San-Julián Mikel, Sierrasesúmaga Lu Similar articles in PubMed
Methylenetetrahydrofolate reductase C677T gene polymorphism in osteosarcoma and chondrosarcoma patients. Folia biologica 2008 54 (2): 53-7. Ozger H, Kilicoglu O, Yilmaz H, Ergen H A, Yaylim I, Zeybek U, Isbir Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Oct 1, 2021
Page last updated:May 11, 2022
Content source:

TOP